Smartleaf Asset Management LLC boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 21.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,904 shares of the financial services provider’s stock after purchasing an additional 685 shares during the period. Smartleaf Asset Management LLC’s holdings in CME Group were worth $904,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. SJS Investment Consulting Inc. boosted its position in CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. Truvestments Capital LLC purchased a new position in shares of CME Group during the 3rd quarter valued at $26,000. Dunhill Financial LLC lifted its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares during the last quarter. Financial Life Planners purchased a new position in shares of CME Group during the 4th quarter valued at $32,000. Finally, Fortitude Family Office LLC lifted its position in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
Shares of NASDAQ CME opened at $256.88 on Tuesday. The firm has a market capitalization of $92.57 billion, a P/E ratio of 26.56, a P/E/G ratio of 6.76 and a beta of 0.57. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock’s 50-day simple moving average is $238.80 and its two-hundred day simple moving average is $229.58. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $257.78.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio is currently 51.71%.
CME Group declared that its Board of Directors has approved a stock repurchase plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its shares are undervalued.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on CME. Oppenheimer upped their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. upped their price target on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research report on Thursday, February 13th. Piper Sandler upped their price target on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Morgan Stanley upped their price target on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Royal Bank of Canada upped their price target on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $236.13.
Check Out Our Latest Stock Report on CME Group
Insiders Place Their Bets
In other news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now owns 27,046 shares in the company, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- 3 Tickers Leading a Meme Stock Revival
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Breakout Stocks: What They Are and How to Identify Them
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.